Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking

OBJECTIVE: Severe cases of coronavirus disease 2019 (COVID-19) are expected to have a worse prognosis than mild cases. Shenhuang Granule (SHG) has been shown to be a safe and effective treatment for severe COVID-19 in a previous randomized clinical trial, but the active chemical constituents and und...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiang-ru, Zhang, Wen, Wu, Xin-xin, Yang, Hong-qiang, Sun, Yu-ting, Pu, Yu-ting, Wang, Bei, Peng, Wei, Sun, Li-hua, Guo, Quan, Zhou, Shuang, Fang, Bang-jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328842/
https://www.ncbi.nlm.nih.gov/pubmed/35934629
http://dx.doi.org/10.1016/j.joim.2022.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328842/
https://www.ncbi.nlm.nih.gov/pubmed/35934629
http://dx.doi.org/10.1016/j.joim.2022.07.005

Ejemplares similares